These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33571371)

  • 21. Epithelium Involving Bilateral Axillary Lymph Nodes: Metastasis, Misplaced, or Mullerian!
    Singh K; Sardana R; Quddus MR; Harigopal M
    Int J Surg Pathol; 2021 May; 29(3):284-288. PubMed ID: 32924678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of GATA3 in breast carcinomas: a review.
    Asch-Kendrick R; Cimino-Mathews A
    Hum Pathol; 2016 Feb; 48():37-47. PubMed ID: 26772397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of immunohistochemistry for detection of metastases in sentinel lymph nodes of non-advanced breast cancer patients.
    Nowikiewicz T; Śrutek E; Zegarski W
    Pol J Pathol; 2015 Mar; 66(1):22-9. PubMed ID: 26017876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA3 Positivity in Benign Radiated Prostate Glands: A Potential Diagnostic Pitfall.
    Wobker SE; Khararjian A; Epstein JI
    Am J Surg Pathol; 2017 Apr; 41(4):557-563. PubMed ID: 28291125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
    Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
    Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary sentinel lymph node examination in breast carcinoma.
    Kelley SW; Komorowski RA; Dayer AM
    Arch Pathol Lab Med; 1999 Jun; 123(6):533-5. PubMed ID: 10383808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of GATA3 immunostaining in tumor diagnosis: a review.
    Ordóñez NG
    Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocervicosis involving axillary lymph nodes: first case report.
    Mukonoweshuro P; McCluggage WG
    Int J Gynecol Pathol; 2014 Nov; 33(6):620-3. PubMed ID: 25272302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong androgen receptor expression can aid in distinguishing GATA3+ metastases.
    Boto A; Harigopal M
    Hum Pathol; 2018 May; 75():63-70. PubMed ID: 29408697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.
    Kondov B; Kondov G; Spirovski Z; Milenkovikj Z; Colanceski R; Petrusevska G; Pesevska M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):81-90. PubMed ID: 28593885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endosalpingiosis of axillary sentinel lymph node: a mimic of metastatic breast carcinoma.
    Ozerdem U; Hoda SA
    Breast J; 2015; 21(2):194-5. PubMed ID: 25583152
    [No Abstract]   [Full Text] [Related]  

  • 38. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
    Mantilla JG; Antic T; Tretiakova M
    Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
    Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
    Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant GATA3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall.
    McDonald TM; Epstein JI
    Am J Surg Pathol; 2021 Mar; 45(3):341-346. PubMed ID: 32769430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.